346 related articles for article (PubMed ID: 21470555)
1. Public-private partnerships in neglected tropical disease control: the role of nongovernmental organisations.
Bush S; Hopkins AD
Acta Trop; 2011 Sep; 120 Suppl 1():S169-72. PubMed ID: 21470555
[TBL] [Abstract][Full Text] [Related]
2. Mectizan(®) procurement and delivery for onchocerciasis mass drug administration programmes.
Ogoussan KT; Hopkins A
Acta Trop; 2011 Sep; 120 Suppl 1():S173-6. PubMed ID: 20974105
[TBL] [Abstract][Full Text] [Related]
3. The Mectizan Donation Program (MDP).
Thylefors B
Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():39-44. PubMed ID: 18718154
[TBL] [Abstract][Full Text] [Related]
4. Mectizan as a stimulus for development of novel partnerships: the international organization's perspective.
Etya'alé DE
Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S73-7. PubMed ID: 9861271
[TBL] [Abstract][Full Text] [Related]
5. The World Bank.
Bangoura O
Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():31-3. PubMed ID: 18718152
[TBL] [Abstract][Full Text] [Related]
6. The Mectizan Donation Program: 20 years of successful collaboration - a retrospective.
Colatrella B
Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():7-11. PubMed ID: 18718147
[TBL] [Abstract][Full Text] [Related]
7. The NGDO Co-ordination Group for Onchocerciasis Control.
Haddad D
Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():35-8. PubMed ID: 18718153
[TBL] [Abstract][Full Text] [Related]
8. Control of onchocerciasis.
Boatin BA; Richards FO
Adv Parasitol; 2006; 61():349-94. PubMed ID: 16735169
[TBL] [Abstract][Full Text] [Related]
9. The Onchocerciasis Control Programme in West Africa (OCP).
Boatin B
Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():13-7. PubMed ID: 18718148
[TBL] [Abstract][Full Text] [Related]
10. Mectizan Donation Program: evaluation of a public-private partnership.
Peters DH; Phillips T
Trop Med Int Health; 2004 Apr; 9(4):A4-15. PubMed ID: 15078275
[TBL] [Abstract][Full Text] [Related]
11. The African Programme for Onchocerciasis Control (APOC).
Amazigo U
Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():19-22. PubMed ID: 18718149
[TBL] [Abstract][Full Text] [Related]
12. Controlling and eliminating neglected diseases in Latin America and the Caribbean.
Bitran R; Martorell B; Escobar L; Munoz R; Glassman A
Health Aff (Millwood); 2009; 28(6):1707-19. PubMed ID: 19887411
[TBL] [Abstract][Full Text] [Related]
13. Health care at the end of the road: opportunities from 20 years of partnership in onchocerciasis control.
Haddad D; Cross C; Thylefors B; Richards FO; Bush S; Hopkins AD; Baker SK
Glob Public Health; 2008; 3(2):187-96. PubMed ID: 19288370
[TBL] [Abstract][Full Text] [Related]
14. Control of neglected tropical diseases needs a long-term commitment.
Zhang Y; MacArthur C; Mubila L; Baker S
BMC Med; 2010 Oct; 8():67. PubMed ID: 21034473
[TBL] [Abstract][Full Text] [Related]
15. GlaxoSmithKline and Merck: private-sector collaboration for the elimination of lymphatic filariasis.
Gustavsen KM; Bradley MH; Wright AL
Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S11-5. PubMed ID: 19843393
[TBL] [Abstract][Full Text] [Related]
16. Progress in public-private partnerships to fight neglected diseases.
Gustavsen K; Hanson C
Health Aff (Millwood); 2009; 28(6):1745-9. PubMed ID: 19887415
[TBL] [Abstract][Full Text] [Related]
17. Impact of ivermectin on illness and disability associated with onchocerciasis.
Tielsch JM; Beeche A
Trop Med Int Health; 2004 Apr; 9(4):A45-56. PubMed ID: 15078278
[TBL] [Abstract][Full Text] [Related]
18. The diagnostics and control of neglected tropical helminth diseases. Foreword.
Kyelem D; Fischer PU; Brattig NW
Acta Trop; 2011 Sep; 120 Suppl 1():S1-3. PubMed ID: 21501582
[No Abstract] [Full Text] [Related]
19. Overcoming the challenges of drug discovery for neglected tropical diseases: the A·WOL experience.
Johnston KL; Ford L; Taylor MJ
J Biomol Screen; 2014 Mar; 19(3):335-43. PubMed ID: 24241712
[TBL] [Abstract][Full Text] [Related]
20. Beyond providing drugs: the Mectizan® donation stimulates new strategies in service delivery and in strengthening health systems.
Hopkins A
Curr Pharm Biotechnol; 2012 May; 13(6):1110-9. PubMed ID: 22039801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
